From: Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
Variables | Diabetes mellitus | P-value | |
---|---|---|---|
Yes = 28 | No = 51 | ||
Age (year) mean ± SD | 30.2 ± 5.8 | 27.4 ± 5.2 | 0.031 |
Hemoglobin (g/dl) mean ± SD | 9.9 ± 0.63 | 9.8 ± 0.69 | 0.636 |
Ferritin (ng/ml) | 1855 ± 1325 | 2434 ± 1737 | 0.129 |
Sex (male) (%) | 28.6 | 31.4 | > 0.999 |
Splenectomy (yes) (%) | 55.6 | 27.5 | 0.026 |
Iron chelation therapy (%) | |||
Deferoxamine | 32.1 | 7.8 | 0.027 |
Deferasirox | 21.4 | 41.2 | |
Deferoxamine and Deferiprone | 35.7 | 33.3 | |
Deferoxamine and Deferasirox | 10.7 | 17.6 | |
Intraocular pressure (mmHg) mean ± SD | 16.17 ± 3.5 | 14.17 ± 3.05 | 0.010 |
VA (logMar) (%) | |||
0–0.1 | 89.3 | 100 | 0.041 |
> 0.1 | 10.7 | 0 | |
Cataract or lens opacity | 10.7 | 2 | 0.125 |
Fundus abnormalities (%) | 10.7 | 9.8 | > 0.999 |